Simmons Bank
Source: SEC Form 13F · as of Mar 2026Simmons Bank holds 17 biotech & pharma companies tracked by BioSniper, totaling $70.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$70.9M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 52,462 | $11.4M |
| AMGNAMGEN INC | 24,825 | $8.7M |
| MRKMerck & Co., Inc. | 71,297 | $8.6M |
| JNJJOHNSON & JOHNSON | 34,243 | $8.4M |
| LLYELI LILLY & Co | 7,784 | $7.2M |
| GILDGILEAD SCIENCES, INC. | 38,221 | $5.3M |
| PFEPFIZER INC | 149,603 | $4.2M |
| ABTABBOTT LABORATORIES | 33,707 | $3.5M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 57,886 | $3.2M |
| REGNREGENERON PHARMACEUTICALS, INC. | 3,946 | $3.0M |
| BMYBRISTOL MYERS SQUIBB CO | 36,219 | $2.2M |
| PMPhilip Morris International Inc | 11,189 | $1.8M |
| NVSNovartis AG | 8,233 | $1.3M |
| MCKMcKesson Corporation | 943 | $816K |
| ZTSZoetis Inc. | 5,265 | $622K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,555 | $421K |
| AZNASTRAZENECA PLC | 1,385 | $273K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.